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CASE REPORT
Type 1 neovascularization 
with polypoidal lesions complicating  
dome shaped macula
Jonathan Naysan1,2,3,4, Kunal K Dansingani1,2,5, Chandrakumar Balaratnasingam1,2,6 and K Bailey Freund1,2,3,4*
Abstract 
Dome-shaped macula is described as an inward bulge of the macula within a posterior staphyloma in highly myopic 
eyes. Choroidal neovascularization is a known complication that can cause visual loss in dome-shaped macula. 
Herein, we describe a patient who presented with features of polypoidal choroidal neovascularization that developed 
on a background of high myopia with dome-shaped macula.
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Background
Dome-shaped macula (DSM) is an inward bulge of 
the macula within a posterior staphyloma in highly 
myopic patients [1]. Recently, Imamura et al. [2] utilized 
enhanced depth optical coherence tomography (EDI-
OCT) to demonstrate that the anterior bulge was con-
sequent to relative increases in scleral thickness beneath 
the macula. Gaucher et  al. [1] reported that the preva-
lence of dome-shaped macula was approximately 10.7% 
in highly myopic eyes. However, recent reports have uti-
lized multimodal imaging to show that the rate of DSM is 
higher and in the range between 15 and 20% [3, 4].
Choroidal neovascularization (CNV) is a known com-
plication of DSM and occurs at a rate of approximately 
20% [4, 5]. Deobhakta et  al. [6] recently demonstrated 
that some eyes with DSM will manifest a shallow pig-
ment epithelial detachment (PED) overlying an area of 
abrupt change in choroidal thickness typically occurring 
at the edge of the dome. They hypothesized that some 
of these flat irregular PEDs might harbor type 1 neovas-
cularization. Herein, we describe the multimodal imag-
ing findings in a patient with DSM who presented with 
type 1 neovascularization with polypidal lesions. To our 
knowledge, polypoidal type 1 neovascularization has not 
been documented in the setting of DSM.
Case presentation
A 50-year-old white female with a history of high myo-
pia presented with metamorphopsia and visual deterio-
ration in her left eye that had developed gradually over 
many months. She had previously been diagnosed with 
central serous chorioretinopathy and had received pho-
todynamic therapy to the left eye after which two intra-
vitreal injections of bevacizumab were administered (last 
treatment was over 1  year previously). She was taking 
metformin for glucose intolerance and was otherwise 
healthy.
Visual acuities were 20/250 in the right eye, improving 
to 20/100 with pinhole and 20/800 in the left eye, improving 
to 20/100 with pinhole. Her refractive error was −7.5 and 
−9.0 diopters right and left, respectively.
The anterior segments were unremarkable and intraoc-
ular pressures were 15 mmHg in both eyes. Ophthalmo-
scopic examination showed peripapillary atrophy and 
retinal pigment epithelial changes that were consist-
ent with myopic degeneration (Figure  1). There was no 
hemorrhage.
Horizontal OCT (Heidelberg Spectralis, Heidelberg 
Engineering, Germany) raster scans did not overtly 
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illustrate any dome configuration of the patient’s macula. 
However, a combination of horizontal and vertical raster 
scans enabled a radially asymmetric three-dimensional 
dome-shaped configuration to be appreciated (Figure 2). 
Spectral domain OCT showed thin choroids in both 
eyes with subfoveal choroidal thickness of 98 and 95 um, 
Figure 1 Color photograph and fundus autofluorescence images of the posterior pole of the left eye show a rectangular area of mottled retinal 
pigment epithelial atrophy arranged with its long axis aligned horizontally.
Figure 2 Topological representations of the posterior pole. Vertical and horizontal raster spectral domain optical coherence tomography line scans 
show that the long axis of the elliptical dome lies in the horizontal meridian, as demonstrated also by a quad-mesh projection onto an elevation-
mapped near-infrared image plane. The region of atrophy lies at the inferior border of the crest of the elliptical dome, where the choroid is thinnest.
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respectively. The vertically oriented OCT line scans 
showed an abrupt change in choroidal thickness occur-
ring at the inferior edge of the dome (Figure 3). EDI-OCT 
confirmed an increase in scleral thickness beneath the 
site of the macular dome.
A complex irregular pigment epithelial detachment 
was noted at the left macula consistent with a polypoidal 
lesion and its associated type 1 branching vascular net-
work (BVN) (Figures  2, 3). Shallow subretinal fluid was 
also seen on these scans. Indocyanine green angiography 
(TRC-50FX, Topcon Corporation, Tokyo, Japan) and split 
spectrum amplitude decorrelation angiography (Avanti, 
Optovue, Fremont, CA, USA) demonstrated the polypoidal 
lesion and its corresponding feeding vessels (Figure 3). The 
Figure 3 Multimodal imaging findings of choroidal neovascularization. Early and transit phase indocyanine green angiographic frames dem-
onstrate perfusion of a choroidal vascular loop at the fovea (green arrowhead) followed by hyperfluorescence of at least three polypoidal lesions 
(red arrowheads) and their feeding network (yellow arrowhead). Magnified horizontal and vertical raster enhanced depth spectral domain optical 
coherence tomographic (OCT) line scans through these areas show the polypoidal lesions as peaked pigment epithelial detachments (PEDs) and 
the feeding network as an adjacent shallow irregular PED. The presence of pathologically dilated choroidal vessels is noted with overlying loss of 
choriocapillaris tissue, especially at the crest of the dome. En face OCT (3 × 3 mm) through the shallow PED reveals the spherical morphology of 
at least three polypoidal lesions. En face OCT angiography (3 × 3 mm) through the PED isolates the type 1 neovascular tissue from the rest of the 
choroid and shows significant flow through the feeder vessels and within the polypoidal lesions.
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ICGA also showed relatively larger caliber choroidal vessels 
in the thicker choroid at the superior edge of the dome.
DSM is associated with high myopia [1] and previous 
reports have shown that this diagnosis can be missed if 
the macula is evaluated with a single OCT scan orien-
tation. Liang et  al. [4] reported that vertical and hori-
zontal OCT scans are necessary to achieve diagnostic 
sensitivity for DSM. In their paper, they showed that 
of those eyes with DSM, the diagnosis could be made 
using only the vertical section in 77% of cases and using 
only the horizontal section in 2% of cases. These find-
ings are reflected in our patient in whom the diagnosis 
of DSM was confirmed only after integration of vertical 
and horizontal OCT scans to construct a three-dimen-
sional structure.
Vision loss from DSM can be consequent to serous 
neurosensory detachment masquerading as central 
serous chorioretinopathy [5]. Foveal retinoschisis [4, 
7] and choroidal neovascularization [1, 7] are other 
known complications that can arise during the natural 
course of DSM. The rate of CNV in DSM is approxi-
mately 20%, however, little information is available 
concerning the morphology of these lesions. Utilizing 
OCT angiography and other imaging modalities, we 
show that CNV in DSM can manifest a polypoidal con-
figuration. Polypoidal neovascular changes have also 
been described in central serous chorioretinopathy [8, 
9], choroidal nevi [10, 11], peripheral exudative hemor-
rhagic chorioretinopathy [12] and optic nerve melano-
cytoma [13].
Conclusion
Scleral thickness at the site of DSM is increased in con-
tradiction to what is usually found in high myopia [14]. 
Previous authors used this observation to postulate that 
control of ocular expansion in myopia may be more 
complex than initially proposed [2]. Polypoidal changes 
to type 1 neovascularization in the setting of DSM may 
reflect the unique stretch and mechanical forces being 
applied to the macula and choroid in this condition. It 
will be important to study other cases of CNV in DSM to 
validate this hypothesis.
Consent
Written informed consent was obtained from the patient 
for publication of this Case report and any accompany-
ing images. A copy of the written consent is available for 
review by the Editor-in-Chief of this journal.
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